Michael Celano

Michael Celano (board member) discloses dealings in 2 companies, chiefly Larimar Therapeutics, Inc. and Orasure Technologies Inc. In total, 9 filings cover trades dated from 17 May 2021 to 26 January 2026.

The open-market record is one-sided, with 3 purchases worth €170k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants.

In size, the median ticket on the buying side is €52k. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 27 January 2026 came the latest disclosure, a share grant in Larimar Therapeutics, Inc. The latest purchase dates back some time: it was published 1,249 days ago, on 18 May 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.